TITLE

Neoadjuvant Chemotherapy with Ifosfamide, Cisplatin, Adriamyecin and Mitomycin (IMAP) for High risk Adult Soft Tissue Sarcomas

AUTHOR(S)
Mohagheghi, Mohammad Ali; Sadighi, Sanambar; Raafat, Jahangir; Mosavi-Jarrahi, Ali Reza; Seddigh, Zahra; Ghaemi, Marjan
PUB. DATE
April 2009
SOURCE
Acta Medica Iranica;2009, Vol. 47 Issue 2, p133
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
To define efficacy of pre-operative chemotherapy in down staging of advanced non-round cell soft tissue sarcomas. From Sep 2002 to Dec 2005, 70 patients were treated by Ifosfamid, MESNA, cisplatin, adriamycin, mitomycin and subsequent surgery. Postoperatively, patients received radiotherapy in cases of microscopically incomplete resection or local recurrence. The median age of the patients was 34 years and the median tumor size was 14 cm. According to AJCC classification 46 patients had stage 3 and 24 had stage 4 diseases. The most common subtypes were MFH and leiomyosarcoma. The most common sites of tumors were lower extremity and trunk. Toxicity grades three or higher consisted of nausea, Leucopenia and infection. About 50% of the patients received G-CSF. Response to chemotherapy was assessable in 63 patients; 9 patients achieved complete response and 16 showed partial response. Disease progressed in 8 and did not change in 37. The best response was seen with MFH, fibrosarcoma and synovial sarcoma. After chemotherapy seventy percent of patients underwent complete surgery. Disease relapsed in 41 patients and twenty two patients died of metastasis. Median survival of patients was 30 months. IMAP plus G-CSF is safe and effective as preoperative chemotherapy in some subtypes of sarcomas, although the metastasis problem has not been eliminated
ACCESSION #
44347675

 

Related Articles

  • Clinicopathological assessment of T1 soft tissue sarcomas. Tsukushi, Satoshi; Nishida, Yoshihiro; Wasa, Junji; Urakawa, Hiroshi; Ishiguro, Naoki // Archives of Orthopaedic & Trauma Surgery;May2011, Vol. 131 Issue 5, p695 

    Introduction: Many studies have identified factors prognostic for soft tissue sarcomas of local recurrence, and distant metastasis. Several studies demonstrated that some subsets of patients could be safely treated by surgery alone, with acceptable rates of local recurrence. The aim of this...

  • Sequential intensified chemotherapy with stem cell rescue for children and adolescents with desmoplastic small round-cell tumor. Bisogno, G.; Ferrari, A.; Rosolen, A.; Alaggio, R.; Scarzello, G.; Garaventa, A.; Arcamone, G.; Carli, M. // Bone Marrow Transplantation;May2010, Vol. 45 Issue 5, p907 

    The RMS4.99 study was designed to explore the role of early sequential intensified chemotherapy (SICT) with PBSC rescue in patients with soft tissue sarcoma with a poor prognosis. Fourteen patients with desmoplastic small round-cell tumor (DSRCT) were included in this study. Initial chemotherapy...

  • The pedicled myocutaneous flap as a choice reconstructive technique for immediate adjuvant brachytherapy in sarcoma treatment. Saba, S. C.; Shaterian, A.; Tokin, C.; Dobke, M. K.; Wallace, A. M. // Current Oncology;Dec2012, Vol. 19 Issue 6, pe491 

    Successful treatment of soft-tissue sarcomas is highly dependent on total tumour resection coupled with adjuvant radiation therapy to achieve local control and decrease recurrence. Reconstruction of soft-tissue defects after resection aims to cover vital structures, while providing enough stable...

  • Trabectedin: An Emerging Therapeutic Option in Soft Tissue Sarcoma. Blay, Jean-Yves // European Journal of Clinical & Medical Oncology;2010, Vol. 2 Issue 1, p1 

    Soft tissue sarcomas (STSs) are a heterogeneous group of solid tumors generally associated with a poor prognosis. Even with optimal treatment for localized disease, approximately 30-50% of patients will develop metastases within two to three years from diagnosis. Chemotherapy is the mainstay of...

  • Long Term Outcome of Preoperative Isolated Limb Infusion and External Irradiation in Management of Locally Advanced Extremity Soft Tissue Sarcoma. Hegazy, Mohamed A.; Elnahas, Waleed; Farouk, Omar; Mosbah, Mahmoud; Hafez, Mohamed; Kotb, Sherif; Sakr, Hanem; Abo Zeid, Waleed; Hendawy, Sayed; Amer, Talal; Hegazi, Rifaat // Open Surgical Oncology Journal;2011, Vol. 3, p14 

    Background: We report our long term results of isolated limb infusion (ILI) in cases of locally advanced soft-tissue sarcoma (ASTS) of the extremities. Methods: Forty cases of ASTS received ILI with doxorubicin. Preoperative external beam radiotherapy started within 3-7 days after ILI was...

  • SARCOAMELE CAPULUI ÅžI GÂTULUI. Gogălniceanu, D.; Trandafir, Violeta; Trandafir, Daniela; Popescu, Eugenia; Costan, V. V.; Vicol, Carmen // Jurnalul de Chirurgie;2009, Vol. 5 Issue 3, p252 

    Sarcomas of the head and neck are rare malignancies constituting about 0,8% of all head and neck tumors. These tumors can arise from either bony or soft tissue, depending on the mesenchymal cells from which they derive. Aim: The aim of this study is to assess the role of radical surgery,...

  • A guide to oncological management of soft tissue tumours of the abdominal wall. Williams, K.; Hayes, A. // Hernia;Feb2014, Vol. 18 Issue 1, p91 

    Introduction: An abdominal mass is a common clinical presentation, and a small percentage of such patients will have an abdominal wall tumour with the two most common pathologies being fibromatosis and soft tissue sarcoma. Methods: Here we present the available literature on the diagnosis and...

  • GHOST Protocol: Greatest Healing Opportunity for Soft Tissue, a Treatment Paradigm for Complex Sarcoma Reconstruction. KOBRAEI, EDWARD M.; EBERLIN, KYLE R.; RICCI, JOSEPH A.; REISH, RICHARD G.; WINOGRAD, JONATHAN M.; CETRULO JR., CURTIS L. // American Surgeon;Jun2015, Vol. 81 Issue 6, p557 

    Modern sarcoma treatment has created new challenges for plastic surgeons. This study was designed to review the recent experience and practice patterns following complex sarcoma resection at a large sarcoma center. All cases from October 2013 to October 2014 involving rare nonepithelial tumors,...

  • Guideline on Dental Management of Pediatric Patients Receiving Chemotherapy, Hematopoietic Cell Transplantation, and/or Radiation.  // Pediatric Dentistry;2010 Reference Manual, Vol. 32 Issue 6, p253 

    The article presents guidelines from the American Academy of Pediatric Dentistry concerning dental management methods for pediatric patients undergoing chemotherapy, radiotherapy, or hematopoietic cell transplantation (HCT). It states that radiotherapy and chemotherapy in cancer treatment or in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics